The global spread of carbapenemase-producing bacteria is alarming and represents a major public health issue, as these bacteria are responsible for an increasing number of infections. The distribution of carbapenemases differs between specific regions or countries [1] . In Germany, OXA-48 is currently the most prevalent carbapenemase, followed by VIM-1 and NDM-1 among Enterobacteriaceae. Of particular concern is the marked increase in isolates producing more than one carbapenemase, as this is usually associated with even greater limitations in treatment options [2] .
Rapid diagnostic techniques are of the utmost importance to improve both patient therapy and the control of spread in hospitals. In response, an increasing number of approaches and solutions have been developed for the clinical microbiology laboratory [1, 3, 4] . Molecular assays based on different formats allow highly sensitive and specific detection of carbapenemase producers [5, 6] . Multiplex immunochromatographic lateral flow tests (ICTs), which have recently become commercially available, seem to be a fast and reliable alternative, requiring fewer technical resources [7] [8] [9] . RESIST-4 (Coris, BioConcept, Gembloux, Belgium) is a novel multiplex ICT for the rapid detection of OXA-48, KPC, NDM and VIM carbapenemases. Compared to its predecessor, RESIST-3 OKN (RESIST-3), the detection spectrum was increased by VIM variants. The goal of this study was to evaluate the performance of RESIST-4 with respect to multidrug-resistant Enterobacteriaceae whose carbapenemase status had been confirmed by the German National Reference Laboratory (NRL) for Multidrug-resistant Gram-negative Bacteria (Ruhr-University Bochum, Germany).
In multidrug-resistant Gram-negative bacteria (MDR-GNB) with decreased carbapenem susceptibility isolated from various clinical specimens in our laboratory, carbapenemase production is routinely confirmed at the molecular level at the German NRL for Multidrug-resistant Gram-negative bacteria (Ruhr-University Bochum, Germany). Isolates Abstract Purpose. The global spread and increasing clinical impact of carbapenemase-producing bacteria are alarming. Rapid diagnostic techniques for carbapenemase detection are of the utmost importance to prevent delays in efficient antibiotic therapy and the control of spread in hospitals. Recently, multiplex immunochromatographic lateral flow tests (ICTs) for the fast detection of carbapenemase-producers have become commercially available. We evaluated a novel multiplex ICT for the rapid detection of OXA-48, KPC, NDM and VIM carbapenemases.
Methodology. One hundred well-characterized multidrug-resistant Enterobacteriaceae were analysed by RESIST-4 (Coris, BioConcept, Gembloux, Belgium). The reference standard included confirmation at the molecular level at the German National Reference Laboratory for multidrug-resistant Gram-negative bacteria (Ruhr-University Bochum, Germany).
Results/Key findings. The tested ICT was highly reliable, showing 100 % sensitivity and 100 % specificity.
Conclusion.
As it is fast, easy to perform and has few technical requirements, the ICT represents a good opportunity to improve turnaround times and patient care for the clinical microbiology laboratory.
are stored at −80 °C afterwards. Out of these MDR-GNB with NRL-confirmed carbapenemase status, a selection of 100 Enterobacteriaceae (OXA-48 n=20, OXA-181 n=2,
were subjected to analysis. The selection was composed of Escherichia coli (n=24), Klebsiella pneumoniae (n=49), Klebsiella oxytoca (n=3), Klebsiella ornithinolytica (n=1), Enterobacter cloacae complex (n=10), Enterobacter aerogenes (n=1), Citrobacter freundii (n=6), Citrobacter koseri (n=1), Citrobacter braakii (n=1) and Serratia marcescens (n=4). In isolates reported as NDM-1/6/16 or NDM-4/12/15 by the NRL, sequencing revealed the highest homologies for the stated carbapenemases, but further differentiation was not possible as these variants do not differ in the sequenced region. Carbapenemase-producing members of the Acinetobacter baumannii complex were excluded, as the most prevalent carbapenemases in these strains are not part of the spectrum of the test.
RESIST-4 is an ICT comprising two cassettes that allows the detection of OXA-48 variants (OXA-48, -162, -181, -204, -232, -244, -245, -436, -484), KPC variants (KPC-1, -2, -3, -4, -9), NDM variants (NDM-1, -2, -4, -5, -6, -7, -9) and VIM variants (VIM-1, -2, -4, -5, -19, -27, -30, -31, -52) on bacterial culture. All tested strains were grown on Columbia blood agar (Becton Dickinson, Heidelberg, Germany). According to the user manual, bacteria were harvested by touching one colony with a disposable bacteriological loop. The loop was dipped in a tube containing 12 drops of LY-A buffer [saline solution buffered to pH 7.5 containing TRIS, NaN 3 (<0.1 %) and a detergent]. After that, the solution was stirred thoroughly and three drops of the diluted sample were added into the well of each of the two cassettes. The final results were read after 15 min. As stated in the manufacturer's instructions, the intensity of the test line may vary according to the quantity of antigens as well as the variant type present in the sample. Any reddish-purple test line, even weak, should be considered as a positive result.
RESIST-4 correctly confirmed 84/84 of the carbapenemaseproducing Enterobacteriaceae, including isolates harbouring two carbapenemases (Fig. 1) . The test showed no false-positive reactions in carbapenemase-negative isolates (Table 1) .
One NDM-producing isolate with the highest homology to NDM-1 and NDM-6 showed a visible but very faint band.
Subcultivation on a selective chromogenic medium (CHROMagar KPC, Mast Diagnostica GmbH, Reinfeld, Germany) led to a clearer and more distinct band in retesting with RESIST-4.
The RESIST-4 assay showed 100 % sensitivity and 100 % specificity in well-characterized multidrug-resistant Enterobacteriaceae. Differences in genus and species did not influence the results. Reading the OXA-48 bands was easiest, because they were clearly visible. Signals for KPC and VIM production were also clear. NDM was hardest to detect and read, as the bands were faint in places. We share this observation with those made in a recent publication on RESIST-3, where the detection of NDM was difficult and led to a falsenegative result in a Proteus mirabilis isolate [7] . However, in our study, each carbapenemase-producing MDR-GNB was detected correctly. In uncertain cases with weak bands, we suggest confirmative testing by plating the isolate on a selective chromogenic agar. Another possibility to reduce difficulties in NDM testing is the use of zinc-supplemented Mueller-Hinton agar (MHA) or the practice of harvesting the isolate adjacent to an ertapenem or meropenem disk [7] .
The extension of RESIST-3 to VIM variants in RESIST-4 was essential as VIM variants belong to the main clinically relevant carbapenemases in Enterobacteriaceae [2] . In our study, the test system was able to detect these variants reliably.
Assuming that RESIST-3 and RESIST-4 are able to identify their predicted carbapenemase targets, we calculated their coverage of the carbapenemase genes detected in Germany by the NRL Bochum in 2017 [2] . The calculated coverage of nationwide carbapenemase genes in Enterobacteriaceae is 97.8 % for RESIST-4 compared to 77.8 % for RESIST-3. So, RESIST-4 would only have missed 2.2 % of the carbapenemase-producing Enterobacteriaceae in 2017. Among Enterobacteriaceae with decreased carbapenem susceptibility tested at the NRL Bochum in 2017, only 45 % were carbapenemase-positive, while 55 % were carbapenemase-negative, showing other mechanisms of resistance [2] . If it misses 2.2 % of these carbapenemase-producing organisms, analysis with RESIST-4 will result in a very low false-negative rate of around 1 % among all Enterobacteriaceae with decreased carbapenem susceptibility. A negative result with RESIST-4 will therefore predict the negativity of carbapenemase production with much greater certainty than RESIST-3.
Under the current epidemiological circumstances, we would not recommend the use of RESIST-4 for the detection of carbapenemases in A. baumannii complex, as the most prevalent carbapenemases of these strains (in particular OXA-23) are not included in the spectrum of this test. However, testing might become necessary as an increase in the diversity of carbapenemases in A. baumannii complex has been observed in recent years [2] .
Overall, RESIST-4 showed excellent performance, in addition to easy handling with regard to technician time and technological needs. Allowing confirmation of carbapenemase production within minutes, it is well suited to prevent delays in efficient antibiotic therapy and the isolation of carriers of carbapenemase producers. Thus, the test system will be implemented in our laboratory and integrated into the diagnostic workflow for Enterobacteriaceae with decreased carbapenem susceptibility in order to provide fast and highly reliable information about the status of carbapenemase production. The continuation of additional molecular testing at the NRL Bochum will allow the prospective evaluation of sensitivity and specificity of RESIST-4 and the surveillance of carbapenemase epidemiology.
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